| 1 |
30266754 | RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer. | 2019 Feb |
1 |
| 2 |
31139406 | Isocitrate dehydrogenase 1-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallate. | 2019 |
1 |
| 3 |
31160965 | Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes. | 2019 |
1 |
| 4 |
29366652 | Synthesis and evaluation of radiolabeled AGI-5198 analogues as candidate radiotracers for imaging mutant IDH1 expression in tumors. | 2018 Feb 15 |
1 |
| 5 |
29382206 | TOF-SIMS analysis of an isocitrate dehydrogenase 1 mutation-associated oncometabolite in cancer cells. | 2018 Jan 30 |
1 |
| 6 |
29879375 | IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity. | 2018 Jun 7 |
1 |
| 7 |
30156013 | Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1. | 2018 Nov |
1 |
| 8 |
25778530 | Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish. | 2015 May 7 |
1 |
| 9 |
25980580 | Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype. | 2015 May 20 |
1 |
| 10 |
26363012 | Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198. | 2015 Nov 15 |
3 |
| 11 |
26368816 | Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells. | 2015 |
2 |
| 12 |
23558169 | An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. | 2013 May 3 |
1 |